• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Author Correction: Head and neck squamous cell carcinoma.

作者信息

Johnson Daniel E, Burtness Barbara, Leemans C René, Lui Vivian Wai Yan, Bauman Julie E, Grandis Jennifer R

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of California at San Francisco, San Francisco, CA, USA.

Department of Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.

出版信息

Nat Rev Dis Primers. 2023 Jan 19;9(1):4. doi: 10.1038/s41572-023-00418-5.

DOI:10.1038/s41572-023-00418-5
PMID:36658129
Abstract
摘要

相似文献

1
Author Correction: Head and neck squamous cell carcinoma.作者更正：头颈部鳞状细胞癌。
Nat Rev Dis Primers. 2023 Jan 19;9(1):4. doi: 10.1038/s41572-023-00418-5.
2
Author Correction: FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.作者更正：FUT8介导的SEMA7A异常N-糖基化促进头颈部鳞状细胞癌进展。
Int J Oral Sci. 2024 Jul 2;16(1):49. doi: 10.1038/s41368-024-00307-x.
3
Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy.作者更正：接受放射治疗的头颈部鳞状细胞癌患者的影像和临床数据存档
Sci Data. 2018 Nov 27;5(1):1. doi: 10.1038/s41597-018-0002-5.
4
Author Correction: NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma.作者更正：头颈部鳞状细胞癌中炎症诱导NOVA1及表观遗传调控抑制NOVA1
Sci Rep. 2020 Nov 30;10(1):21299. doi: 10.1038/s41598-020-77481-5.
5
Immunotherapy for squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌的免疫治疗。
Jpn J Clin Oncol. 2020 Sep 28;50(10):1089-1096. doi: 10.1093/jjco/hyaa139.
6
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.帕博利珠单抗治疗头颈部复发或转移性鳞状细胞癌的安全性和临床活性（KEYNOTE-012）：一项开放标签、多中心、1b 期试验。
Lancet Oncol. 2016 Jul;17(7):956-965. doi: 10.1016/S1470-2045(16)30066-3. Epub 2016 May 27.
7
Correlation between PET/CT and CT in the staging prior to the treatment of head and neck squamous cell carcinoma.头颈部鳞状细胞癌治疗前的 PET/CT 与 CT 分期的相关性。
Braz J Otorhinolaryngol. 2021 Jan-Feb;87(1):11-18. doi: 10.1016/j.bjorl.2019.06.004. Epub 2019 Jul 6.
8
Diffusion tensor imaging in differentiation of residual head and neck squamous cell carcinoma from post-radiation changes.扩散张量成像在鉴别头颈部残留鳞状细胞癌与放疗后改变中的应用
Magn Reson Imaging. 2018 Dec;54:84-89. doi: 10.1016/j.mri.2018.08.009. Epub 2018 Aug 21.
9
Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.南亚头颈部鳞状细胞癌中表皮生长因子受体（EGFR）的免疫组织化学表达：与各种风险因素及临床病理和预后参数的关系。
World J Surg Oncol. 2018 Jun 28;16(1):118. doi: 10.1186/s12957-018-1425-3.
10
MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.MRI 弥散加权成像在头颈部鳞癌治疗后检测中的应用：形态学 MRI 标准为何重要。
AJNR Am J Neuroradiol. 2018 Apr;39(4):748-755. doi: 10.3174/ajnr.A5548. Epub 2018 Feb 15.

引用本文的文献

1
Salivaomic Biomarkers-An Innovative Approach to the Diagnosis, Treatment, and Prognosis of Oral Cancer.唾液生物标志物——口腔癌诊断、治疗和预后的创新方法。
Biology (Basel). 2025 Jul 13;14(7):852. doi: 10.3390/biology14070852.
2
Comparative Efficacy of Treatments for Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer.头颈部癌患者放射性口腔黏膜炎治疗方法的疗效比较
Cureus. 2025 Jun 16;17(6):e86145. doi: 10.7759/cureus.86145. eCollection 2025 Jun.
3
Risk factors associated with prognosis in patients with osteoradionecrosis of the jaws: A single institutional experience over 15 years.
颌骨放射性骨坏死患者预后的相关危险因素：一项15年的单机构经验。
Med Oral Patol Oral Cir Bucal. 2025 Jul 1;30(4):e597-e604. doi: 10.4317/medoral.27164.
4
Pan-immune-inflammatory value and systemic immune-inflammatory index in relation to osteoradionecrosis of the jaws: a single institutional experience over 15 years.与颌骨放射性骨坏死相关的泛免疫炎症值和全身免疫炎症指数：一项15年的单机构经验
Odontology. 2025 Apr 8. doi: 10.1007/s10266-025-01101-9.
5
Vessel Co-option: A Promising Therapeutic Strategy in Oral Squamous Cell Carcinoma.血管共选：口腔鳞状细胞癌中一种有前景的治疗策略。
Cureus. 2025 Feb 24;17(2):e79572. doi: 10.7759/cureus.79572. eCollection 2025 Feb.
6
Head and Neck Cancer in Pan-American Notable People: An International Survey.泛美名人中的头颈癌：一项国际调查。
Dent J (Basel). 2024 Sep 26;12(10):305. doi: 10.3390/dj12100305.
7
Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.阿培利司联合免疫治疗：复发性和转移性头颈部鳞状细胞癌的有前途的联合治疗方案。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70023. doi: 10.1002/cnr2.70023.
8
Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer-Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies.间质干细胞/基质细胞在头颈部癌症中的作用——肿瘤发生和免疫活性、化疗耐药性的调控机制，以及基于间质细胞的药理学策略的治疗益处。
Cells. 2024 Jul 28;13(15):1270. doi: 10.3390/cells13151270.
9
Cancer and immune response: The role of PD-1/PD-L1 checkpoint in laryngeal carcinoma. Preliminary results.癌症与免疫反应：PD-1/PD-L1 检查点在喉癌中的作用。初步结果。
Eur Arch Otorhinolaryngol. 2024 Oct;281(10):5411-5417. doi: 10.1007/s00405-024-08822-7. Epub 2024 Jul 28.
10
Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.头颈部鳞状细胞癌中巨噬细胞的特征分析及基于 MRG 的风险特征的建立。
Sci Rep. 2024 Apr 30;14(1):9914. doi: 10.1038/s41598-024-60516-6.